Chronic rhinosinusitis disease control: a review of the history and the evidence

References

• Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;58:1–464. doi: 10.4193/Rhin20.401
   Web of Science ®Google Scholar
• Orlandi RR, Kingdom TT, Smith TL, et al. International consensus statement on allergy and rhinology: rhinosinusitis 2021. Int Forum Allergy Rhinol. 2021;11(3):213–739. doi: 10.1002/alr.22741
   PubMed Web of Science ®Google Scholar
• Wahid NW, Smith R, Clark A, et al. The socioeconomic cost of chronic rhinosinusitis study. Rhinology. 2020;58(2):112–125. doi: 10.4193/Rhin19.424
   PubMed Web of Science ®Google Scholar
• Sedaghat AR, Kuan EC, Scadding GK. Epidemiology of chronic rhinosinusitis: prevalence and risk factors. J Allergy Clin Immunol Pract. 2022;10(6):1395–1403. doi: 10.1016/j.jaip.2022.01.016
   PubMed Web of Science ®Google Scholar
• Sedaghat A, Hopkins C. Chronic rhinosinusitis disease control as a metric for guiding treatment. Rhinology. 2020;58:193.
   PubMed Web of Science ®Google Scholar
• Sedaghat AR, Phillips KM. Defining ‘control’ of chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg. 2023;31(1):17–23. doi: 10.1097/MOO.0000000000000858
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. NHLBI/WHO workshop report. National Institutes of Health, National Heart, Lung and Blood Institute (National Institutes of Health publication no. 95-3659); 1995.
   Google Scholar
• EPR-3. NAEPP expert panel report 3: guidelines for the diagnosis and treatment of asthma. Bethesda (MD): US Department of Health and Human Services; National Institutes of Health; National Heart, Lung, and Blood Institute, 2007.
   Google Scholar
• Global Initiative for Asthma (GINA). National heart, lung and blood institute (NHLBI) global strategy for asthma management and prevention. Nat Inst Health, Nat Heart, Lung And Blood Institute. 2006.
   Google Scholar
• Bateman ED, Frith LF, Braunstein GL. Achieving guideline-based asthma control: does the patient benefit? Eur Respir J. 2002;20:588–595. doi: 10.1183/09031936.02.00294702
   PubMed Web of Science ®Google Scholar
• Zhang J, Yin C, Li H, et al. Application of once-monthly self-reported ACT questionnaire in management of adherence to inhalers in outpatients with asthma. Patient Prefer Adherence. 2020;14:1027–1036. doi: 10.2147/PPA.S176683
   PubMed Web of Science ®Google Scholar
• Papaioannou AI, Kostikas K, Zervas E, et al. Control of asthma in real life: still a valuable goal? Eur Respir Rev. 2015;24(136):361–369. doi: 10.1183/16000617.00001615
   PubMed Web of Science ®Google Scholar
• Fokkens WJ, Lund VJ, Mullol J, et al. European position paper on rhinosinusitis and nasal polyps 2012. RhinologySupplement. 2012;23:298.
   Google Scholar
• van der Veen J, Seys SF, Timmermans M, et al. Real-life study showing uncontrolled rhinosinusitis after sinus surgery in a tertiary referral centre. Allergy. 2017;72:282–290. doi: 10.1111/all.12983
   PubMed Web of Science ®Google Scholar
• Phillips KM, Singerman KW, Sedaghat AR. Individual symptom visual analogue scale severity scores for determining EPOS guideline-based chronic rhinosinusitis disease control. Rhinology. 2022;60:229–235. doi: 10.4193/Rhin21.446
   PubMed Web of Science ®Google Scholar
• de Loos DAE D, Cornet ME, Hopkins C, et al. Measuring control of disease in chronic rhinosinusitis; assessing the correlation between sinonasal outcome test-22 and visual analogue scale item scores. Rhinology. 2023;61:39–46. doi: 10.4193/Rhin21.275
   PubMed Web of Science ®Google Scholar
• Snidvongs K, Heller GZ, Sacks R, et al. Validity of European position paper on rhinosinusitis disease control assessment and modifications in chronic rhinosinusitis. Otolaryngol Head Neck Surg Offic J Am J Otolaryngol-Head Neck Surg. 2014;150:479–486. doi: 10.1177/0194599813517080
   PubMed Web of Science ®Google Scholar
• Banglawala SM, Schlosser RJ, Morella K, et al. Qualitative development of the sinus control test: a survey evaluating sinus symptom control. Int Forum Allergy Rhinol. 2016;6(5):491–499. doi: 10.1002/alr.21690
   PubMed Web of Science ®Google Scholar
• Kohli P, Soler ZM, Storck KA, et al. Responsiveness and reliability of the sinus control test in chronic rhinosinusitis. Rhinology. 2017;55(1):39–44. doi: 10.4193/Rhin16.208
   PubMed Web of Science ®Google Scholar
• Little RE, Schlosser RJ, Smith TL, et al. Disease control after surgery for chronic rhinosinusitis: prospective, multi-institutional validation of the sinus control test. Int Forum Allergy Rhinol. 2021;11(2):106–114. doi: 10.1002/alr.22659
   PubMed Web of Science ®Google Scholar
• Gengler I, Kavoosi TA, McCann AC, et al. Patient perspectives on recall period and response options in patient-reported outcome measures for chronic rhinosinusitis symptomatology: a pilot study. Clinical Otolaryngology: Official Journal Of ENT-UK; Official Journal Of Netherlands Society For Oto-Rhino-Laryngology & Cervico-Facial Surgery. 2021;46(5):1021–1027. doi: 10.1111/coa.13774
   PubMed Web of Science ®Google Scholar
• Hopkins C, Hettige R, Soni-Jaiswal A, et al. Chronic Rhinosinusitis Outcome MEasures (CHROME), developing a core outcome set for trials of interventions in chronic rhinosinusitis. Rhinology. 2018;56(1):22–32. doi: 10.4193/Rhin17.247
   PubMed Web of Science ®Google Scholar
• Ali A, Fakunle DR, Yu V, et al. Heterogeneity in the definition of chronic rhinosinusitis disease control: a systematic review of the scientific literature. Eur Arch Otorhinolaryngol. 2023. doi: 10.1007/s00405-023-08090-x.
   Web of Science ®Google Scholar
• Bachert C, Han JK, Desrosiers M, et al. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet. 2019;394(10209):1638–1650. doi: 10.1016/S0140-6736(19)31881-1
   PubMed Web of Science ®Google Scholar
• de Oliveira IS, Guimaraes AF, Arantes Pegas GF, et al. Azithromycin for chronic eosinophilic rhinosinusitis with nasal polyp: a placebo-controlled trial. Rhinology. 2020;58:610–617.
   PubMed Web of Science ®Google Scholar
• Grayson JW, Li W, Ho J, et al. Topography of polyp recurrence in eosinophilic chronic rhinosinusitis. Int Forum Allergy Rhinol. 2020;10(5):604–609. doi: 10.1002/alr.22529
   PubMed Web of Science ®Google Scholar
• Walker V, Trope M, Tichavakunda AA, et al. Disease control in chronic rhinosinusitis: a qualitative study of patient perspectives. Rhinology. 2022;60:282–292.
   PubMed Web of Science ®Google Scholar
• Gray ST, Hoehle LP, Phillips KM, et al. Patient-reported control of chronic rhinosinusitis symptoms is positively associated with general health-related quality of life. Clinical Otolaryngology: Official Journal Of ENT-UK; Official Journal Of Netherlands Society For Oto-Rhino-Laryngology & Cervico-Facial Surgery. 2017;42(6):1161–1166. doi: 10.1111/coa.12841
   PubMed Web of Science ®Google Scholar
• Gray ST, Phillips KM, Hoehle LP, et al. The 22-item Sino-Nasal Outcome Test accurately reflects patient-reported control of chronic rhinosinusitis symptomatology. Int Forum Allergy Rhinol. 2017;7(10):945–951. doi: 10.1002/alr.21992
   PubMed Web of Science ®Google Scholar
• Phillips KM, Houssein FA, Singerman K, et al. Patient-reported chronic rhinosinusitis disease control is a valid measure of disease burden. Rhinology. 2021;59:545–551.
   PubMed Web of Science ®Google Scholar
• Sedaghat AR, Hoehle LP, Gray ST. Chronic rhinosinusitis control from the patient and physician perspectives. Laryngoscope Investig Otolaryngol. 2018;3:419–433.
   PubMed Web of Science ®Google Scholar
• McCann AC, Trope M, Walker VL, et al. Olfactory dysfunction is not a determinant of patient-reported chronic rhinosinusitis disease control. Laryngoscope. 2021;131(7):E2116–E20. doi: 10.1002/lary.29280
   PubMed Web of Science ®Google Scholar
• Mattos JL, Rudmik L, Schlosser RJ, et al. Symptom importance, patient expectations, and satisfaction in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2019;9(6):593–600. doi: 10.1002/alr.22309
   PubMed Web of Science ®Google Scholar
• Liu DT, Besser G, Prem B, et al. Individual importance of olfaction decreases with duration of smell loss. Rhinology. 2021;59(1):32–39. doi: 10.4193/Rhin20.196
   PubMed Web of Science ®Google Scholar
• Liu DT, Philips KM, Speth MM, et al. Item response theory for psychometric properties of the SNOT-22 (22-item sinonasal outcome test). Otolaryngol Head Neck Surg. 2021;166:580–588. doi: 10.1177/01945998211018383
   PubMed Web of Science ®Google Scholar
• Feng AL, Wesely NC, Hoehle LP, et al. A validated model for the 22-item sino-nasal outcome test subdomain structure in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2017;7(12):1140–1148. doi: 10.1002/alr.22025
   PubMed Web of Science ®Google Scholar
• Hoehle LP, Phillips KM, Bergmark RW, et al. Symptoms of chronic rhinosinusitis differentially impact general health-related quality of life. Rhinology. 2016;54(4):316–322. doi: 10.4193/Rhino16.211
   PubMed Web of Science ®Google Scholar
• Speth MM, Hoehle LP, Phillips KM, et al. Changes in chronic rhinosinusitis symptoms differentially associate with improvement in general health-related quality of life. Ann Allergy Asthma Immunol. 2018;121(2):195–199. doi: 10.1016/j.anai.2018.05.029
   PubMed Web of Science ®Google Scholar
• Yamasaki A, Hoehle LP, Phillips KM, et al. Association between systemic antibiotic and corticosteroid use for chronic rhinosinusitis and quality of life. Laryngoscope. 2018;128(1):37–42. doi: 10.1002/lary.26778
   PubMed Web of Science ®Google Scholar
• Banoub RG, Phillips KM, Hoehle LP, et al. Relationship between chronic rhinosinusitis exacerbation frequency and asthma control. Laryngoscope. 2018;128(5):1033–1038. doi: 10.1002/lary.26901
   PubMed Web of Science ®Google Scholar
• Phillips KM, Hoehle LP, Bergmark RW, et al. Acute exacerbations mediate quality of life impairment in chronic rhinosinusitis. J Allergy Clin Immunol Pract. 2017;5(2):422–426. doi: 10.1016/j.jaip.2016.09.015
   PubMed Web of Science ®Google Scholar
• Phillips KM, Speth MM, Shu ET, et al. Validity of systemic antibiotics and systemic corticosteroid usage for chronic rhinosinusitis as metrics of disease burden. Rhinology. 2020;58(3):194–199. doi: 10.4193/Rhin19.248
   PubMed Web of Science ®Google Scholar
• Walters ZA, Sedaghat AR, Phillips KM. Acute exacerbations of chronic rhinosinusitis: the current state of knowledge. Laryngoscope Investig Otolaryngol. 2022;7(4):935–942. doi: 10.1002/lio2.857
   PubMed Web of Science ®Google Scholar
• Sedaghat AR, Singerman KW, Phillips KM. Discordance of chronic rhinosinusitis disease control between EPOS guidelines and patient perspectives identifies utility of patient-rated control assessment. Rhinology. 2022;60:444–452.
   PubMed Web of Science ®Google Scholar
• Sedaghat AR, Caradonna DS, Chandra RK, et al. Determinants of physician assessment of chronic rhinosinusitis disease control using EPOS 2020 criteria and the importance of incorporating patient perspectives of disease control. Int Forum Allergy Rhinol. 2023. doi: 10.1002/alr.23168
   Web of Science ®Google Scholar
• Sedaghat AR. Treating objective outcome measures of chronic rhinosinusitis: are we making the patient or ourselves feel better? Rhinology. 2022;60(5):321. doi: 10.4193/Rhin22.905
   PubMed Web of Science ®Google Scholar
• Jeong SS, Chen T, Nguyen SA, et al. Correlation of polyp grading scales with patient symptom scores and olfaction in chronic rhinosinusitis: a systematic review and meta-analysis. Rhinology. 2022. doi: 10.4193/Rhin22.011
   Web of Science ®Google Scholar
• Speth MM, Gaudin RA, Hoehle LP, et al. Reciprocal predictive accuracy of sinonasal symptom severity, nasal endoscopy, and frequency of past chronic rhinosinusitis exacerbations. Otolaryngol Head Neck Surg. 2018;159(4):766–773. doi: 10.1177/0194599818774741
   PubMed Web of Science ®Google Scholar
• Bateman ED, Boushey HA, Bousquet J, et al. Can guideline-defined asthma control be achieved? The gaining optimal asthma ControL study. Am J Respir Crit Care Med. 2004;170(8):836–844. doi: 10.1164/rccm.200401-033OC
   PubMed Web of Science ®Google Scholar
• Lourijsen ES, Reitsma S, Vleming M, et al. Endoscopic sinus surgery with medical therapy versus medical therapy for chronic rhinosinusitis with nasal polyps: a multicentre, randomised, controlled trial. Lancet Respir Med. 2022;10(4):337–346. doi: 10.1016/S2213-2600(21)00457-4
   PubMed Web of Science ®Google Scholar
• Calus L, Van Bruaene N, Bosteels C, et al. Twelve-year follow-up study after endoscopic sinus surgery in patients with chronic rhinosinusitis with nasal polyposis. Clin Transl Allergy. 2019;9(1):30. doi: 10.1186/s13601-019-0269-4
   PubMedGoogle Scholar